Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Donata Benedetti

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
World Journal of Clinical Cases|August 6, 2015
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?Alberto Gajofatto, Maria Donata Benedetti
Expert Review of Neurotherapeutics|November 14, 2014
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophyMassimiliano Calabrese, Alberto Gajofatto, Maria Donata Benedetti
Expert Review of Neurotherapeutics|November 5, 2016
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectivesAlberto Gajofatto, Marco Turatti, Maria Donata Benedetti
Drug, Healthcare and Patient Safety|December 31, 2015
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisAlberto Gajofatto, Marco Turatti, Salvatore Monaco, et al.
Disease Markers|December 11, 2013
Clinical, MRI, and CSF markers of disability progression in multiple sclerosisAlberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 14, 2011
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluidManuel Cappellari, Fabio Benedetti, Antonio Fiaschi, et al.
Mini Reviews in Medicinal Chemistry|August 12, 2008
Azathioprine in multiple sclerosisPaolo Invernizzi, Maria Donata Benedetti, Sarah Poli, et al.
European Neurology|September 18, 2014
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational studyAlberto Gajofatto, Maria Rachele Bianchi, Luciano Deotto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 13, 2010
Long survival and clinical stability in Marburg's variant multiple sclerosisMarco Turatti, Alberto Gajofatto, Francesca Rossi, et al.
International Journal of Molecular Sciences|December 17, 2011
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?Alberto Gajofatto, Matilde Bongianni, Gianluigi Zanusso, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
World Journal of Clinical Cases|August 6, 2015
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?Alberto Gajofatto, Maria Donata Benedetti
Expert Review of Neurotherapeutics|November 14, 2014
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophyMassimiliano Calabrese, Alberto Gajofatto, Maria Donata Benedetti
Expert Review of Neurotherapeutics|November 5, 2016
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectivesAlberto Gajofatto, Marco Turatti, Maria Donata Benedetti
Drug, Healthcare and Patient Safety|December 31, 2015
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisAlberto Gajofatto, Marco Turatti, Salvatore Monaco, et al.
Disease Markers|December 11, 2013
Clinical, MRI, and CSF markers of disability progression in multiple sclerosisAlberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 14, 2011
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluidManuel Cappellari, Fabio Benedetti, Antonio Fiaschi, et al.
Mini Reviews in Medicinal Chemistry|August 12, 2008
Azathioprine in multiple sclerosisPaolo Invernizzi, Maria Donata Benedetti, Sarah Poli, et al.
European Neurology|September 18, 2014
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational studyAlberto Gajofatto, Maria Rachele Bianchi, Luciano Deotto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 13, 2010
Long survival and clinical stability in Marburg's variant multiple sclerosisMarco Turatti, Alberto Gajofatto, Francesca Rossi, et al.
International Journal of Molecular Sciences|December 17, 2011
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?Alberto Gajofatto, Matilde Bongianni, Gianluigi Zanusso, et al.
Pageof 4